Structure

Physi-Chem Properties

Molecular Weight:  534.32
Volume:  571.846
LogP:  4.344
LogD:  3.281
LogS:  -3.74
# Rotatable Bonds:  15
TPSA:  103.67
# H-Bond Aceptor:  8
# H-Bond Donor:  3
# Rings:  3
# Heavy Atoms:  8

MedChem Properties

QED Drug-Likeness Score:  0.306
Synthetic Accessibility Score:  3.954
Fsp3:  0.452
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Rejected
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -5.93
MDCK Permeability:  1.386016720061889e-05
Pgp-inhibitor:  0.001
Pgp-substrate:  0.006
Human Intestinal Absorption (HIA):  0.013
20% Bioavailability (F20%):  0.01
30% Bioavailability (F30%):  0.004

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.274
Plasma Protein Binding (PPB):  94.54813385009766%
Volume Distribution (VD):  1.193
Pgp-substrate:  2.621680974960327%

ADMET: Metabolism

CYP1A2-inhibitor:  0.027
CYP1A2-substrate:  0.1
CYP2C19-inhibitor:  0.246
CYP2C19-substrate:  0.908
CYP2C9-inhibitor:  0.776
CYP2C9-substrate:  0.726
CYP2D6-inhibitor:  0.055
CYP2D6-substrate:  0.312
CYP3A4-inhibitor:  0.702
CYP3A4-substrate:  0.7

ADMET: Excretion

Clearance (CL):  3.537
Half-life (T1/2):  0.77

ADMET: Toxicity

hERG Blockers:  0.024
Human Hepatotoxicity (H-HT):  0.827
Drug-inuced Liver Injury (DILI):  0.952
AMES Toxicity:  0.002
Rat Oral Acute Toxicity:  0.843
Maximum Recommended Daily Dose:  0.095
Skin Sensitization:  0.012
Carcinogencity:  0.047
Eye Corrosion:  0.003
Eye Irritation:  0.006
Respiratory Toxicity:  0.091

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC469938

Natural Product ID:  NPC469938
Common Name*:   Ixorapeptide Ii
IUPAC Name:   (2S,3S)-2-[[2-[[(2S)-2-(dimethylamino)-3-phenylpropanoyl]amino]-3-indol-1-yl-4-methylpentanoyl]amino]-3-methylpentanoic acid
Synonyms:   Ixorapeptide Ii
Standard InCHIKey:  DPHRDZLCFBXNED-FSSQJUNMSA-N
Standard InCHI:  InChI=1S/C31H42N4O4/c1-7-21(4)26(31(38)39)32-30(37)27(28(20(2)3)35-18-17-23-15-11-12-16-24(23)35)33-29(36)25(34(5)6)19-22-13-9-8-10-14-22/h8-18,20-21,25-28H,7,19H2,1-6H3,(H,32,37)(H,33,36)(H,38,39)/t21-,25-,26-,27?,28?/m0/s1
SMILES:  CC[C@@H]([C@@H](C(=O)O)N=C(C(C(n1ccc2c1cccc2)C(C)C)N=C([C@@H](N(C)C)Cc1ccccc1)O)O)C
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL1288092
PubChem CID:   50925590
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000264] Organic acids and derivatives
      • [CHEMONTID:0000265] Carboxylic acids and derivatives
        • [CHEMONTID:0000013] Amino acids, peptides, and analogues
          • [CHEMONTID:0000348] Peptides
            • [CHEMONTID:0004831] Oligopeptides

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO6876 Ixora coccinea Species Rubiaceae Eukaryota aerial parts collected on the campus of Kaohsiung Medical University, Taiwan 2007-Oct PMID[21106454]
NPO6876 Ixora coccinea Species Rubiaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. IC50 = 0.21 ug.mL-1 PMID[473590]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. IC50 = 0.27 ug.mL-1 PMID[473590]
NPT2 Others Unspecified Ratio IC50 = 73.0 n.a. PMID[473590]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC469938 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.8772 High Similarity NPC94752
0.8466 Intermediate Similarity NPC117244
0.8466 Intermediate Similarity NPC473763
0.8352 Intermediate Similarity NPC213629
0.8343 Intermediate Similarity NPC293917
0.8249 Intermediate Similarity NPC321708
0.8229 Intermediate Similarity NPC228835
0.8208 Intermediate Similarity NPC126709
0.8208 Intermediate Similarity NPC213468
0.8208 Intermediate Similarity NPC248041
0.8208 Intermediate Similarity NPC283219
0.8201 Intermediate Similarity NPC75634
0.8198 Intermediate Similarity NPC267885
0.8166 Intermediate Similarity NPC160105
0.815 Intermediate Similarity NPC14113
0.815 Intermediate Similarity NPC84827
0.815 Intermediate Similarity NPC145885
0.814 Intermediate Similarity NPC149155
0.814 Intermediate Similarity NPC110500
0.814 Intermediate Similarity NPC203468
0.8138 Intermediate Similarity NPC478158
0.8136 Intermediate Similarity NPC235684
0.8118 Intermediate Similarity NPC473376
0.8108 Intermediate Similarity NPC476874
0.8087 Intermediate Similarity NPC171317
0.8081 Intermediate Similarity NPC314603
0.8032 Intermediate Similarity NPC54420
0.8 Intermediate Similarity NPC11126
0.7989 Intermediate Similarity NPC472323
0.7989 Intermediate Similarity NPC473640
0.7977 Intermediate Similarity NPC477976
0.7966 Intermediate Similarity NPC143533
0.7957 Intermediate Similarity NPC475506
0.7953 Intermediate Similarity NPC474561
0.7953 Intermediate Similarity NPC49954
0.7952 Intermediate Similarity NPC25008
0.7952 Intermediate Similarity NPC469765
0.7952 Intermediate Similarity NPC469763
0.7952 Intermediate Similarity NPC73952
0.7952 Intermediate Similarity NPC469786
0.7952 Intermediate Similarity NPC469760
0.7952 Intermediate Similarity NPC259644
0.7947 Intermediate Similarity NPC162860
0.7927 Intermediate Similarity NPC478157
0.7917 Intermediate Similarity NPC129721
0.7914 Intermediate Similarity NPC155143
0.7907 Intermediate Similarity NPC78020
0.7907 Intermediate Similarity NPC63751
0.7904 Intermediate Similarity NPC80597
0.7904 Intermediate Similarity NPC212376
0.7904 Intermediate Similarity NPC70922
0.7904 Intermediate Similarity NPC75540
0.7904 Intermediate Similarity NPC211572
0.7898 Intermediate Similarity NPC248462
0.7897 Intermediate Similarity NPC281049
0.7892 Intermediate Similarity NPC474916
0.7889 Intermediate Similarity NPC17059
0.7853 Intermediate Similarity NPC15840
0.7849 Intermediate Similarity NPC100321
0.7841 Intermediate Similarity NPC64436
0.7833 Intermediate Similarity NPC62749
0.7821 Intermediate Similarity NPC165495
0.7819 Intermediate Similarity NPC193761
0.7819 Intermediate Similarity NPC57398
0.7811 Intermediate Similarity NPC469762
0.7797 Intermediate Similarity NPC219336
0.7784 Intermediate Similarity NPC54744
0.7778 Intermediate Similarity NPC282231
0.7778 Intermediate Similarity NPC280290
0.776 Intermediate Similarity NPC107077
0.776 Intermediate Similarity NPC223791
0.7751 Intermediate Similarity NPC469785
0.7749 Intermediate Similarity NPC323927
0.7742 Intermediate Similarity NPC262898
0.774 Intermediate Similarity NPC217372
0.774 Intermediate Similarity NPC183662
0.774 Intermediate Similarity NPC59269
0.774 Intermediate Similarity NPC15573
0.7733 Intermediate Similarity NPC194640
0.7733 Intermediate Similarity NPC311276
0.7732 Intermediate Similarity NPC31385
0.7732 Intermediate Similarity NPC110602
0.7732 Intermediate Similarity NPC75726
0.7722 Intermediate Similarity NPC472119
0.7719 Intermediate Similarity NPC279918
0.7711 Intermediate Similarity NPC319232
0.7711 Intermediate Similarity NPC24370
0.7709 Intermediate Similarity NPC113626
0.7701 Intermediate Similarity NPC201700
0.7688 Intermediate Similarity NPC179701
0.768 Intermediate Similarity NPC15102
0.764 Intermediate Similarity NPC111275
0.7637 Intermediate Similarity NPC478077
0.7634 Intermediate Similarity NPC289299
0.7634 Intermediate Similarity NPC57994
0.763 Intermediate Similarity NPC478182
0.7626 Intermediate Similarity NPC477714
0.7619 Intermediate Similarity NPC40070
0.7612 Intermediate Similarity NPC64216
0.7611 Intermediate Similarity NPC233936
0.7611 Intermediate Similarity NPC71037
0.7606 Intermediate Similarity NPC149708
0.7605 Intermediate Similarity NPC470111
0.7598 Intermediate Similarity NPC55772
0.7593 Intermediate Similarity NPC150259
0.759 Intermediate Similarity NPC314372
0.759 Intermediate Similarity NPC320968
0.7586 Intermediate Similarity NPC477975
0.7582 Intermediate Similarity NPC62510
0.7557 Intermediate Similarity NPC194411
0.7556 Intermediate Similarity NPC91179
0.7556 Intermediate Similarity NPC469896
0.7554 Intermediate Similarity NPC175474
0.7543 Intermediate Similarity NPC56233
0.7543 Intermediate Similarity NPC54988
0.7542 Intermediate Similarity NPC68354
0.7542 Intermediate Similarity NPC326575
0.7542 Intermediate Similarity NPC234987
0.7541 Intermediate Similarity NPC474707
0.754 Intermediate Similarity NPC195239
0.754 Intermediate Similarity NPC157828
0.7529 Intermediate Similarity NPC40779
0.7526 Intermediate Similarity NPC470497
0.7515 Intermediate Similarity NPC24678
0.7515 Intermediate Similarity NPC105818
0.7513 Intermediate Similarity NPC238457
0.75 Intermediate Similarity NPC11445
0.75 Intermediate Similarity NPC133261
0.75 Intermediate Similarity NPC472116
0.7488 Intermediate Similarity NPC220852
0.7488 Intermediate Similarity NPC323752
0.7487 Intermediate Similarity NPC477715
0.7486 Intermediate Similarity NPC472122
0.7486 Intermediate Similarity NPC24594
0.7485 Intermediate Similarity NPC314102
0.7485 Intermediate Similarity NPC251722
0.7473 Intermediate Similarity NPC472104
0.7473 Intermediate Similarity NPC472097
0.7473 Intermediate Similarity NPC243716
0.747 Intermediate Similarity NPC190296
0.7462 Intermediate Similarity NPC153980
0.7462 Intermediate Similarity NPC6865
0.7462 Intermediate Similarity NPC207020
0.7459 Intermediate Similarity NPC65215
0.7459 Intermediate Similarity NPC24864
0.7459 Intermediate Similarity NPC173028
0.7457 Intermediate Similarity NPC293487
0.7447 Intermediate Similarity NPC294693
0.7444 Intermediate Similarity NPC248454
0.7442 Intermediate Similarity NPC51054
0.7432 Intermediate Similarity NPC258480
0.743 Intermediate Similarity NPC275305
0.743 Intermediate Similarity NPC37423
0.7426 Intermediate Similarity NPC473317
0.7421 Intermediate Similarity NPC470499
0.7421 Intermediate Similarity NPC265576
0.7421 Intermediate Similarity NPC102008
0.7421 Intermediate Similarity NPC212213
0.7416 Intermediate Similarity NPC478028
0.7414 Intermediate Similarity NPC131718
0.7411 Intermediate Similarity NPC72956
0.7405 Intermediate Similarity NPC204565
0.7396 Intermediate Similarity NPC477974
0.7396 Intermediate Similarity NPC300183
0.7391 Intermediate Similarity NPC472107
0.7391 Intermediate Similarity NPC79062
0.7389 Intermediate Similarity NPC203754
0.7389 Intermediate Similarity NPC150048
0.7389 Intermediate Similarity NPC155444
0.7387 Intermediate Similarity NPC313640
0.7381 Intermediate Similarity NPC28945
0.7381 Intermediate Similarity NPC285343
0.7377 Intermediate Similarity NPC48938
0.7374 Intermediate Similarity NPC471194
0.7374 Intermediate Similarity NPC471193
0.7368 Intermediate Similarity NPC227582
0.7363 Intermediate Similarity NPC472105
0.7363 Intermediate Similarity NPC187827
0.7363 Intermediate Similarity NPC300688
0.7358 Intermediate Similarity NPC471313
0.7358 Intermediate Similarity NPC471311
0.7356 Intermediate Similarity NPC135141
0.7356 Intermediate Similarity NPC92796
0.7351 Intermediate Similarity NPC315555
0.7351 Intermediate Similarity NPC66210
0.7349 Intermediate Similarity NPC469767
0.7349 Intermediate Similarity NPC469761
0.7349 Intermediate Similarity NPC469783
0.7349 Intermediate Similarity NPC469779
0.7349 Intermediate Similarity NPC469784
0.7349 Intermediate Similarity NPC469780
0.7349 Intermediate Similarity NPC469768
0.7348 Intermediate Similarity NPC151939
0.7346 Intermediate Similarity NPC478029
0.7345 Intermediate Similarity NPC478183
0.7345 Intermediate Similarity NPC41717
0.7343 Intermediate Similarity NPC326363
0.7341 Intermediate Similarity NPC285469
0.734 Intermediate Similarity NPC47190
0.7337 Intermediate Similarity NPC472294

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC469938 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8596 High Similarity NPD5728 Clinical (unspecified phase)
0.8512 High Similarity NPD750 Phase 2
0.8483 Intermediate Similarity NPD7818 Clinical (unspecified phase)
0.8427 Intermediate Similarity NPD7944 Discontinued
0.8343 Intermediate Similarity NPD7621 Clinical (unspecified phase)
0.8251 Intermediate Similarity NPD7903 Clinical (unspecified phase)
0.8171 Intermediate Similarity NPD2095 Phase 2
0.8171 Intermediate Similarity NPD2092 Phase 2
0.8171 Intermediate Similarity NPD2094 Phase 2
0.814 Intermediate Similarity NPD482 Approved
0.8125 Intermediate Similarity NPD2091 Phase 2
0.8125 Intermediate Similarity NPD2096 Phase 2
0.8092 Intermediate Similarity NPD749 Clinical (unspecified phase)
0.8032 Intermediate Similarity NPD8493 Clinical (unspecified phase)
0.8024 Intermediate Similarity NPD4326 Phase 2
0.8012 Intermediate Similarity NPD4640 Approved
0.8012 Intermediate Similarity NPD4639 Approved
0.8012 Intermediate Similarity NPD4638 Approved
0.7989 Intermediate Similarity NPD6375 Clinical (unspecified phase)
0.7968 Intermediate Similarity NPD8072 Approved
0.7965 Intermediate Similarity NPD4184 Clinical (unspecified phase)
0.7958 Intermediate Similarity NPD8013 Clinical (unspecified phase)
0.7958 Intermediate Similarity NPD7470 Discontinued
0.7955 Intermediate Similarity NPD6452 Discontinued
0.7944 Intermediate Similarity NPD8110 Clinical (unspecified phase)
0.7919 Intermediate Similarity NPD5934 Clinical (unspecified phase)
0.7914 Intermediate Similarity NPD8073 Approved
0.7914 Intermediate Similarity NPD5721 Clinical (unspecified phase)
0.7884 Intermediate Similarity NPD7958 Clinical (unspecified phase)
0.7884 Intermediate Similarity NPD7957 Phase 1
0.7875 Intermediate Similarity NPD2896 Discontinued
0.7853 Intermediate Similarity NPD5898 Approved
0.7853 Intermediate Similarity NPD5897 Approved
0.7853 Intermediate Similarity NPD5899 Approved
0.7846 Intermediate Similarity NPD8406 Clinical (unspecified phase)
0.7831 Intermediate Similarity NPD8272 Phase 2
0.7826 Intermediate Similarity NPD7619 Phase 3
0.7826 Intermediate Similarity NPD7618 Phase 3
0.7821 Intermediate Similarity NPD6178 Phase 3
0.7812 Intermediate Similarity NPD7998 Clinical (unspecified phase)
0.7754 Intermediate Similarity NPD6661 Clinical (unspecified phase)
0.7753 Intermediate Similarity NPD6595 Phase 3
0.774 Intermediate Similarity NPD8122 Approved
0.774 Intermediate Similarity NPD8123 Approved
0.7737 Intermediate Similarity NPD7712 Clinical (unspecified phase)
0.772 Intermediate Similarity NPD7825 Clinical (unspecified phase)
0.7717 Intermediate Similarity NPD6665 Discontinued
0.7717 Intermediate Similarity NPD5505 Discontinued
0.7713 Intermediate Similarity NPD8248 Clinical (unspecified phase)
0.7709 Intermediate Similarity NPD4383 Clinical (unspecified phase)
0.7697 Intermediate Similarity NPD8037 Clinical (unspecified phase)
0.7697 Intermediate Similarity NPD8036 Clinical (unspecified phase)
0.7692 Intermediate Similarity NPD8431 Approved
0.7692 Intermediate Similarity NPD3961 Discontinued
0.7667 Intermediate Similarity NPD4345 Clinical (unspecified phase)
0.766 Intermediate Similarity NPD6999 Discontinued
0.766 Intermediate Similarity NPD7000 Clinical (unspecified phase)
0.7656 Intermediate Similarity NPD6838 Clinical (unspecified phase)
0.7653 Intermediate Similarity NPD8112 Clinical (unspecified phase)
0.7651 Intermediate Similarity NPD7469 Discontinued
0.765 Intermediate Similarity NPD7233 Approved
0.765 Intermediate Similarity NPD7234 Approved
0.7641 Intermediate Similarity NPD7594 Clinical (unspecified phase)
0.7634 Intermediate Similarity NPD4602 Approved
0.7629 Intermediate Similarity NPD7809 Clinical (unspecified phase)
0.7627 Intermediate Similarity NPD5065 Approved
0.7626 Intermediate Similarity NPD8405 Clinical (unspecified phase)
0.7617 Intermediate Similarity NPD7947 Clinical (unspecified phase)
0.7611 Intermediate Similarity NPD8408 Discontinued
0.7606 Intermediate Similarity NPD4397 Phase 1
0.7605 Intermediate Similarity NPD1661 Suspended
0.7605 Intermediate Similarity NPD4703 Approved
0.7605 Intermediate Similarity NPD4702 Approved
0.7604 Intermediate Similarity NPD7001 Phase 3
0.76 Intermediate Similarity NPD4779 Clinical (unspecified phase)
0.7598 Intermediate Similarity NPD4076 Approved
0.7598 Intermediate Similarity NPD4079 Approved
0.7586 Intermediate Similarity NPD2915 Discontinued
0.7582 Intermediate Similarity NPD6610 Clinical (unspecified phase)
0.7576 Intermediate Similarity NPD8000 Clinical (unspecified phase)
0.7574 Intermediate Similarity NPD2882 Phase 1
0.7563 Intermediate Similarity NPD7971 Clinical (unspecified phase)
0.7563 Intermediate Similarity NPD7970 Approved
0.756 Intermediate Similarity NPD3576 Approved
0.756 Intermediate Similarity NPD3575 Approved
0.7554 Intermediate Similarity NPD6965 Clinical (unspecified phase)
0.7551 Intermediate Similarity NPD8093 Discontinued
0.7543 Intermediate Similarity NPD4174 Clinical (unspecified phase)
0.7542 Intermediate Similarity NPD3506 Approved
0.7542 Intermediate Similarity NPD2144 Approved
0.7542 Intermediate Similarity NPD3505 Approved
0.7542 Intermediate Similarity NPD6203 Clinical (unspecified phase)
0.754 Intermediate Similarity NPD4427 Phase 2
0.7526 Intermediate Similarity NPD7665 Phase 2
0.7526 Intermediate Similarity NPD7666 Phase 3
0.7515 Intermediate Similarity NPD4805 Approved
0.7514 Intermediate Similarity NPD6281 Approved
0.7514 Intermediate Similarity NPD3038 Discontinued
0.7513 Intermediate Similarity NPD4862 Clinical (unspecified phase)
0.75 Intermediate Similarity NPD5069 Clinical (unspecified phase)
0.75 Intermediate Similarity NPD5862 Discovery
0.75 Intermediate Similarity NPD2390 Clinical (unspecified phase)
0.7487 Intermediate Similarity NPD5017 Discontinued
0.7486 Intermediate Similarity NPD1568 Clinical (unspecified phase)
0.7485 Intermediate Similarity NPD2809 Approved
0.7473 Intermediate Similarity NPD4949 Discontinued
0.747 Intermediate Similarity NPD3717 Discontinued
0.7461 Intermediate Similarity NPD6987 Phase 1
0.7451 Intermediate Similarity NPD7711 Discontinued
0.7443 Intermediate Similarity NPD5611 Phase 2
0.7443 Intermediate Similarity NPD4554 Clinical (unspecified phase)
0.7432 Intermediate Similarity NPD4957 Phase 2
0.743 Intermediate Similarity NPD5322 Clinical (unspecified phase)
0.7421 Intermediate Similarity NPD53 Approved
0.7421 Intermediate Similarity NPD7777 Approved
0.7421 Intermediate Similarity NPD7778 Approved
0.7418 Intermediate Similarity NPD4399 Phase 2
0.7415 Intermediate Similarity NPD7730 Approved
0.7415 Intermediate Similarity NPD7731 Approved
0.7414 Intermediate Similarity NPD2511 Approved
0.7407 Intermediate Similarity NPD3385 Approved
0.7407 Intermediate Similarity NPD7061 Clinical (unspecified phase)
0.7405 Intermediate Similarity NPD4948 Discontinued
0.7405 Intermediate Similarity NPD6141 Clinical (unspecified phase)
0.7402 Intermediate Similarity NPD7271 Approved
0.7396 Intermediate Similarity NPD4547 Phase 3
0.7396 Intermediate Similarity NPD7817 Phase 1
0.7394 Intermediate Similarity NPD4804 Approved
0.7391 Intermediate Similarity NPD4336 Clinical (unspecified phase)
0.7391 Intermediate Similarity NPD5555 Phase 1
0.738 Intermediate Similarity NPD4918 Discontinued
0.738 Intermediate Similarity NPD6630 Clinical (unspecified phase)
0.7374 Intermediate Similarity NPD1037 Clinical (unspecified phase)
0.7371 Intermediate Similarity NPD5901 Discontinued
0.7371 Intermediate Similarity NPD8026 Phase 1
0.7366 Intermediate Similarity NPD4334 Discontinued
0.7366 Intermediate Similarity NPD7603 Discontinued
0.7365 Intermediate Similarity NPD2006 Phase 2
0.7365 Intermediate Similarity NPD4637 Clinical (unspecified phase)
0.7356 Intermediate Similarity NPD5255 Approved
0.7351 Intermediate Similarity NPD5809 Phase 3
0.7348 Intermediate Similarity NPD1272 Clinical (unspecified phase)
0.7348 Intermediate Similarity NPD4181 Approved
0.7343 Intermediate Similarity NPD7824 Approved
0.7337 Intermediate Similarity NPD8094 Discontinued
0.7333 Intermediate Similarity NPD4128 Approved
0.7333 Intermediate Similarity NPD6732 Clinical (unspecified phase)
0.733 Intermediate Similarity NPD8129 Discovery
0.733 Intermediate Similarity NPD4987 Clinical (unspecified phase)
0.733 Intermediate Similarity NPD1631 Approved
0.733 Intermediate Similarity NPD6846 Clinical (unspecified phase)
0.7329 Intermediate Similarity NPD3475 Approved
0.7329 Intermediate Similarity NPD3476 Approved
0.7326 Intermediate Similarity NPD3870 Clinical (unspecified phase)
0.7326 Intermediate Similarity NPD3871 Clinical (unspecified phase)
0.7321 Intermediate Similarity NPD7951 Approved
0.7321 Intermediate Similarity NPD7950 Approved
0.7321 Intermediate Similarity NPD7789 Approved
0.7321 Intermediate Similarity NPD7790 Approved
0.7321 Intermediate Similarity NPD7953 Approved
0.7321 Intermediate Similarity NPD7791 Approved
0.7321 Intermediate Similarity NPD7952 Approved
0.7314 Intermediate Similarity NPD6454 Clinical (unspecified phase)
0.7313 Intermediate Similarity NPD8325 Phase 3
0.7313 Intermediate Similarity NPD8327 Clinical (unspecified phase)
0.7313 Intermediate Similarity NPD8326 Phase 3
0.7312 Intermediate Similarity NPD3486 Clinical (unspecified phase)
0.7312 Intermediate Similarity NPD8021 Approved
0.7312 Intermediate Similarity NPD3002 Clinical (unspecified phase)
0.7312 Intermediate Similarity NPD8020 Approved
0.7306 Intermediate Similarity NPD7727 Phase 2
0.7305 Intermediate Similarity NPD5020 Approved
0.7302 Intermediate Similarity NPD2717 Phase 2
0.7296 Intermediate Similarity NPD8322 Phase 2
0.7295 Intermediate Similarity NPD7781 Approved
0.7295 Intermediate Similarity NPD7780 Approved
0.7293 Intermediate Similarity NPD4075 Phase 2
0.7293 Intermediate Similarity NPD5104 Approved
0.7293 Intermediate Similarity NPD5471 Phase 3
0.7293 Intermediate Similarity NPD5501 Discontinued
0.7289 Intermediate Similarity NPD786 Approved
0.7288 Intermediate Similarity NPD5744 Clinical (unspecified phase)
0.7288 Intermediate Similarity NPD4550 Clinical (unspecified phase)
0.7283 Intermediate Similarity NPD2391 Clinical (unspecified phase)
0.7282 Intermediate Similarity NPD5426 Phase 3
0.7282 Intermediate Similarity NPD8114 Approved
0.7282 Intermediate Similarity NPD8115 Approved
0.7278 Intermediate Similarity NPD5995 Clinical (unspecified phase)
0.7278 Intermediate Similarity NPD966 Clinical (unspecified phase)
0.7277 Intermediate Similarity NPD7948 Phase 1
0.7277 Intermediate Similarity NPD6664 Approved
0.7273 Intermediate Similarity NPD5315 Discontinued
0.7267 Intermediate Similarity NPD510 Phase 1
0.7267 Intermediate Similarity NPD3654 Approved
0.7263 Intermediate Similarity NPD1573 Approved
0.7263 Intermediate Similarity NPD1575 Approved
0.7262 Intermediate Similarity NPD4047 Discontinued
0.7254 Intermediate Similarity NPD4601 Approved
0.7254 Intermediate Similarity NPD484 Approved
0.7254 Intermediate Similarity NPD4600 Approved

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data